Ironsides Asset Advisors, LLC Precision Biosciences Inc Transaction History

Ironsides Asset Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$9.18 - $14.15 $96,417 - $148,617	-10,503 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$8.07 - $12.52 $25,856 - $40,114	-3,204 Reduced 23.37%	10,503 $131,000
Q1 2021 May 07, 2021	BUY	$8.57 - $15.79 $22,659 - $41,748	2,644 Added 23.9%	13,707 $142,000
Q4 2020 Feb 10, 2021	SELL	$5.98 - $12.47 $6,063 - $12,644	-1,014 Reduced 8.4%	11,063 $92,000
Q3 2020 Nov 10, 2020	SELL	$4.65 - $8.73 $13,498 - $25,343	-2,903 Reduced 19.38%	12,077 $74,000
Q1 2020 May 11, 2020	BUY	$5.05 - $15.01 $75,649 - $224,849	14,980 New	14,980 $90,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Ironsides Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ironsides Asset Advisors, LLC with notifications on news.